535 related articles for article (PubMed ID: 10750518)
1. Influence of health education on community participation in rapid assessment of onchocerciasis prior to distribution of ivermectin.
Shu EN; Nwadike KI; Onwujekwe EO; Ugwu OC; Okonkwo PO
East Afr Med J; 1999 Jun; 76(6):320-3. PubMed ID: 10750518
[TBL] [Abstract][Full Text] [Related]
2. Control of onchocerciasis in Nzerem-Ikpem, Nigeria: baseline prevalence and mass distribution of ivermectin.
Abanobi OC; Anosike JC
Public Health; 2000 Sep; 114(5):402-6. PubMed ID: 11035465
[TBL] [Abstract][Full Text] [Related]
3. Onchocerciasis in Anambra State, Southeast Nigeria: clinical and psychological aspects and sustainability of community directed treatment with ivermectin (CDTI).
Mbanefo EC; Eneanya CI; Nwaorgu OC; Oguoma VM; Otiji MO; Ogolo BA
Postgrad Med J; 2010 Oct; 86(1020):573-7. PubMed ID: 20971709
[TBL] [Abstract][Full Text] [Related]
4. The African Programme for Onchocerciasis Control: impact on onchocercal skin disease.
Ozoh GA; Murdoch ME; Bissek AC; Hagan M; Ogbuagu K; Shamad M; Braide EI; Boussinesq M; Noma MM; Murdoch IE; Sékétéli A; Amazigo UV
Trop Med Int Health; 2011 Jul; 16(7):875-83. PubMed ID: 21481109
[TBL] [Abstract][Full Text] [Related]
5. A health club for a community school in south-eastern Nigeria: influence on adult perception of onchocerciasis and compliance with community-based ivermectin therapy.
Shu EN; Onwujekwe EO; Lokili P; Okonkwo PO
Trop Med Int Health; 2000 Mar; 5(3):222-6. PubMed ID: 10747286
[TBL] [Abstract][Full Text] [Related]
6. Rapid epidemiological mapping of onchocerciasis in areas of Uganda where Simulium neavei sl is the vector.
Katabarwa M; Onapa AW; Nakileza B
East Afr Med J; 1999 Aug; 76(8):440-6. PubMed ID: 10520349
[TBL] [Abstract][Full Text] [Related]
7. Community financing of local ivermectin distribution in Nigeria: potential payment and cost-recovery outlook.
Onwujekwe OE; Shu EN; Okonkwo PO
Trop Doct; 2000 Apr; 30(2):91-4. PubMed ID: 10842555
[TBL] [Abstract][Full Text] [Related]
8. Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa.
Murdoch ME; Asuzu MC; Hagan M; Makunde WH; Ngoumou P; Ogbuagu KF; Okello D; Ozoh G; Remme J
Ann Trop Med Parasitol; 2002 Apr; 96(3):283-96. PubMed ID: 12061975
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of community compliance with annual ivermectin treatment of onchocerciasis in Patigi, Nigeria.
Oyibo WA; Fagbenro-Beyiku AF
East Afr Med J; 1998 Apr; 75(4):237-42. PubMed ID: 9745842
[TBL] [Abstract][Full Text] [Related]
10. Endemicity of onchocerciasis in some local government areas of Niger state.
Idowu ET; Adewale B; Mafe MA; Appelt B; Bamgbose A
Afr J Med Med Sci; 2004 Mar; 33(1):31-4. PubMed ID: 15490791
[TBL] [Abstract][Full Text] [Related]
11. Health education and community participation in the control of urinary schistosomiasis in Ghana.
Aryeetey ME; Aholu C; Wagatsuma Y; Bentil G; Nkrumah FK; Kojima S
East Afr Med J; 1999 Jun; 76(6):324-9. PubMed ID: 10750519
[TBL] [Abstract][Full Text] [Related]
12. Maintaining compliance to ivermectin in communities in two West African countries.
Whitworth JA; Alexander ND; Seed P; Thomas W; Abiose A; Jones BR
Health Policy Plan; 1996 Sep; 11(3):299-307. PubMed ID: 10160375
[TBL] [Abstract][Full Text] [Related]
13. Health education to school children in Okpatu, Nigeria: impact on onchocerciasis-related knowledge.
Shu EN; Okonkwo PO; Onwujekwe EO
Public Health; 1999 Sep; 113(5):215-8. PubMed ID: 10557114
[TBL] [Abstract][Full Text] [Related]
14. Validation of reports of nodules dissolution after repeated ivermectin treatment of onchocerciasis in southeastern Nigeria.
Ukaga CC; Dozie IN; Nwoke BE
East Afr Med J; 2001 Oct; 78(10):515-7. PubMed ID: 11921593
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with coverage in community-directed treatment with ivermectin for onchocerciasis control in Oyo State, Nigeria.
Brieger WR; Otusanya SA; Oke GA; Oshiname FO; Adeniyi JD
Trop Med Int Health; 2002 Jan; 7(1):11-8. PubMed ID: 11851950
[TBL] [Abstract][Full Text] [Related]
16. Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria.
Ojurongbe O; Akindele AA; Adeleke MA; Oyedeji MO; Adedokun SA; Ojo JF; Akinleye CA; Bolaji OS; Adefioye OA; Adeyeba OA
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003633. PubMed ID: 25812086
[TBL] [Abstract][Full Text] [Related]
17. The effect of 5 years of annual treatment with ivermectin (Mectizan) on the prevalence and morbidity of onchocerciasis in the village of Gami in the Central African Republic.
Kennedy MH; Bertocchi I; Hopkins AD; Meredith SE
Ann Trop Med Parasitol; 2002 Apr; 96(3):297-307. PubMed ID: 12061976
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting the attrition of community-directed distributors of ivermectin, in an onchocerciasis-control programme in the Imo and Abia states of south-eastern Nigeria.
Emukah EC; Enyinnaya U; Olaniran NS; Akpan EA; Hopkins DR; Miri ES; Amazigo U; Okoronkwo C; Stanley A; Rakers L; Richards FO; Katabarwa MN
Ann Trop Med Parasitol; 2008 Jan; 102(1):45-51. PubMed ID: 18186977
[TBL] [Abstract][Full Text] [Related]
19. The selection and validation of indicators for monitoring progress towards self-sustainment in community-directed, ivermectin-treatment programmes for onchocerciasis control in Uganda.
Katabarwa MN; Mutabazi D
Ann Trop Med Parasitol; 1998 Dec; 92(8):859-68. PubMed ID: 10396346
[TBL] [Abstract][Full Text] [Related]
20. Reduced prevalence of onchocerciasis following mass treatment with ivermectin.
Oyibo WA; Fagbenro-Beyioku AF
East Afr Med J; 1997 May; 74(5):326-30. PubMed ID: 9337014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
